GSVSX
Price
$16.62
Change
-$0.08 (-0.48%)
Updated
Sep 5 closing price
Net Assets
433.04M
VVIAX
Price
$71.19
Change
-$0.24 (-0.34%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

GSVSX vs VVIAX

Header iconGSVSX vs VVIAX Comparison
Open Charts GSVSX vs VVIAXBanner chart's image
Goldman Sachs Large Cap Value Svc
Price$16.62
Change-$0.08 (-0.48%)
VolumeN/A
Net Assets433.04M
Vanguard Value Index Adm
Price$71.19
Change-$0.24 (-0.34%)
VolumeN/A
Net Assets202.84B
GSVSX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GSVSX vs. VVIAX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSVSX is a StrongBuy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 203B vs. GSVSX (433M). VVIAX pays higher dividends than GSVSX: VVIAX (2.10) vs GSVSX (0.84). GSVSX was incepted earlier than VVIAX: GSVSX (26 years) vs VVIAX (25 years). GSVSX (1.39) is less costly to investors than VVIAX (0.05). GSVSX is a more actively managed with annual turnover of: 51.00 vs. VVIAX (9.00). GSVSX has a lower initial minimum investment than VVIAX: GSVSX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 7.74 vs. GSVSX (-2.39). VVIAX return over 5 years is better than : 70.16 vs. GSVSX (24.40).
GSVSXVVIAXGSVSX / VVIAX
Total Expense Ratio1.200.052,400%
Annual Report Gross Expense Ratio1.390.052,780%
Fund Existence26 years25 years-
Gain YTD5.7927.85074%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets433M203B0%
Annual Yield % from dividends0.842.1040%
Returns for 1 year-2.397.74-31%
Returns for 3 years14.8436.6141%
Returns for 5 years24.4070.1635%
Returns for 10 years10.78131.618%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMCX7.560.20
+2.72%
AMC Networks
INMB1.950.03
+1.56%
INmune Bio
ACGLN18.080.19
+1.06%
Arch Capital Group Ltd
ARDX6.52-0.05
-0.76%
Ardelyx
HQY91.48-6.22
-6.37%
HealthEquity